Selected article for: "acute ards respiratory distress syndrome and long short"

Author: Tan, Li Yin; Komarasamy, Thamil Vaani; RMT Balasubramaniam, Vinod
Title: Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword
  • Cord-id: 2bj4in2y
  • Document date: 2021_9_30
  • ID: 2bj4in2y
    Snippet: The coronavirus disease-19 (COVID-19) elicited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused devastating health, economic and social impact worldwide. Its clinical spectrum ranges from asymptomatic to respiratory failure and multi-organ failure or death. The pathogenesis of SARS-CoV-2 infection is attributed to a complex interplay between virus and host immune response. It involves activation of multiple inflammatory pathways leading to hyperinflammation and cyto
    Document: The coronavirus disease-19 (COVID-19) elicited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused devastating health, economic and social impact worldwide. Its clinical spectrum ranges from asymptomatic to respiratory failure and multi-organ failure or death. The pathogenesis of SARS-CoV-2 infection is attributed to a complex interplay between virus and host immune response. It involves activation of multiple inflammatory pathways leading to hyperinflammation and cytokine storm, resulting in tissue damage, acute respiratory distress syndrome (ARDS) and multi-organ failure. Accumulating evidence has raised concern over the long-term health effects of COVID-19. Importantly, the neuroinvasive potential of SARS-CoV-2 may have devastating consequences in the brain. This review provides a conceptual framework on how the virus tricks the host immune system to induce infection and cause severe disease. We also explore the key differences between mild and severe COVID-19 and its short- and long-term effects, particularly on the human brain.

    Search related documents:
    Co phrase search for related documents
    • abnormal inflammatory and acute ards respiratory distress syndrome: 1, 2, 3
    • abnormal inflammatory and acute lung injury: 1
    • abnormal inflammatory and acute phase: 1, 2, 3
    • abnormal inflammatory response and acute ards respiratory distress syndrome: 1, 2
    • abnormal inflammatory response and acute lung injury: 1
    • abnormal inflammatory response and acute phase: 1, 2
    • accessory protein and activator kinase signal transducer: 1
    • accessory protein and activator transcription: 1, 2, 3
    • accessory protein and acute ards respiratory distress syndrome: 1
    • accessory protein and acute lung injury: 1
    • activator kinase signal transducer and acute lung injury: 1
    • activator transcription and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6
    • activator transcription and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10